Abstract:Abstract The hypothalamus is a central regulator of physiological homeostasis. During development, multiple transcription factors coordinate the patterning and specification of hypothalamic nuclei. However, the molecular mechanisms controlling hypothalamic patterning and cell fate specification are poorly understood. To identify genes that control these processes, we have used single-cell RNA sequencing (scRNA-Seq) to profile mouse hypothalamic gene expression across multiple developmental time points. We have further utilised scRNA-Seq to phenotype mutations in genes that play major roles in early hypothalamic patterning. To first understand hypothalamic development, hypothalami were collected at both embryonic (E10-E16, E18) and postnatal (PN4, PN8, PN14, PN45) time points. At early stages, when the bulk of hypothalamic patterning occurs (E11-E13), we observe a clear separation between mitotic progenitors and postmitotic neural precursor cells. We likewise observed clean segregation among cells expressing regional hypothalamic markers identified in previous large-scale analysis of hypothalamic development. This analysis reveals new region-specific markers and identifies candidate genes for selectively regulating patterning and cell fate specification in individual hypothalamic regions. With our rich dataset of developing mouse hypothalamus, we integrated our dataset with the Allen Brain Atlas in situ data, publicly available adult hypothalamic scRNA-Seq dataset to understand hierarchy of hypothalamic cell differentiation, as well as re-defining cell types of the hypothalamus. We next used scRNA-Seq to phenotype multiple mutant lines, including a line that has been extensively characterised as a proof of concept (Ctnnb1 overexpression), and lines that have not been characterised (Nkx2.1, Nkx2.2, Dlx1/2 deletion). We show that this approach can rapidly and comprehensively characterize mutants that have altered hypothalamic patterning, and in doing so, have identified multiple genes that simultaneously repress posterior hypothalamic identity while promoting prethalamic identity. This result supports a modified columnar model of organization for the diencephalon, where prethalamus and hypothalamus are situated in adjacent dorsal and ventral domains of the anterior diencephalon. These data serve as a resource for further studies of hypothalamic development and dysfunction, and able to delineate transcriptional regulatory networks of hypothalamic formation. Lastly, using our mouse hypothalamus as a guideline, we are comparing dataset of developing chicken, zebrafish and human hypothalamus, to identify evolutionarily conserved and divergent region-specific gene regulatory networks. We aim to use this knowledge and information of key molecular pathways of human hypothalamic development and produce human hypothalamus organoids.

Modeling hypothalamic pathophysiology in vitro for metabolic, circadian, and sleep disorders

Engineering Three-Dimensional Microenvironments Towards in Vitro Disease Models of the Central Nervous System

Human In Vitro Models of Neuroenergetics and Neurometabolic Disturbances: Current Advances and Clinical Perspectives

Scalable Hypothalamic Arcuate Neuron Differentiation from Human Pluripotent Stem Cells Suitable for Modeling Metabolic and Reproductive Disorders

Model Roles of the Hypothalamo-Neurohypophysial System in Neuroscience Study

Hypothalamic circuits and aging: keeping the circadian clock updated

In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline

In vitro cell models merging circadian rhythms and brain waves for personalized neuromedicine

Challenges and Frontiers in Computational Metabolic Psychiatry

Organoids as Model Systems to Investigate Circadian Clock-Related Diseases and Treatments

In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain-striatum-cortex assembloids

Cortico-thalamic development and disease: From cells, to circuits, to schizophrenia

MON-719 The Cellular and Molecular Landscape of Hypothalamic Patterning and Differentiation

Optogenetic and chemogenetic approaches for modeling neurological disorders in vivo

Tissue-Engineered Models of the Human Brain: State-of-the-Art Analysis and Challenges

Basic models to advanced systems: harnessing the power of organoids-based microphysiological models of the human brain

Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview

Preclinical Models of Cardiac Disease: A Comprehensive Overview for Clinical Scientists

Control of tuberal hypothalamic development and its implications in metabolic disorders

Modeling Neurodegenerative Diseases Using In Vitro Compartmentalized Microfluidic Devices

Human Brain Organoid: A Versatile Tool for Modeling Neurodegeneration Diseases and for Drug Screening